Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CD47–Signal regulatory protein alpha (SIRPα) protein–protein interface is a critical innate immune checkpoint that regulates the phagocytic activity of myeloid cells, particularly macrophages (UniProt P61273, P78324). CD47, a transmembrane protein known as the "don't eat me" signal, is expressed on the surface of most normal cells to prevent their destruction by the immune system. When CD47 binds to SIRPα on macrophages, it initiates an inhibitory signaling pathway that prevents phagocytosis (Chao et al., 2012). Many cancer types exploit this mechanism by overexpressing CD47, allowing them to evade immune surveillance and clearance (Logtenberg et al., 2020). Therapeutic agents targeting this interface, such as monoclonal antibodies and SIRPα-Fc fusion proteins, aim to block this interaction and restore the ability of macrophages to engulf and destroy malignant cells (Advani et al., 2018). However, the ubiquitous expression of CD47 on healthy cells, especially red blood cells, presents a significant clinical challenge, often resulting in treatment-related anemia and hemagglutination (Zhang et al., 2020).
Blockade of the CD47-SIRPα interaction to neutralize the inhibitory 'don't eat me' signal, thereby promoting macrophage-mediated phagocytosis of tumor cells.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD47–Signal regulatory protein alpha (SIRPα) protein–protein interface (CD47–SIRPα interface).